Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toby M Maher

Showing results (131-140 of 391) with videos related to

Pageof 40
Sort By:
Thorax|March 22, 2013
Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatmentHarpreet K Lota, Gregory J Keir, David M Hansell, et al.
The European Respiratory Journal|April 23, 2016
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosisMichael Kreuter, Marlies S Wijsenbeek, Martina Vasakova, et al.
ERJ Open Research|February 17, 2022
Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung diseaseKarim Boustani, Poonam Ghai, Rachele Invernizzi, et al.
Advances in Therapy|May 27, 2020
Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USAAmy L Olson, Toby M Maher, Valentina Acciai, et al.
International Journal of Molecular Sciences|November 14, 2019
The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary FibrosisPaolo Spagnolo, Philip L Molyneaux, Nicol Bernardinello, et al.
Lung|May 13, 2025
Kappa and Mu Opioid Receptors in Chronic Cough: Current Evidence and Future TreatmentSurinder S Birring, Peter V Dicpinigaitis, Toby M Maher, et al.
Frontiers in Immunology|July 5, 2021
Enhanced IL-1β Release Following NLRP3 and AIM2 Inflammasome Stimulation Is Linked to mtROS in Airway Macrophages in Pulmonary FibrosisAthina Trachalaki, Eliza Tsitoura, Semeli Mastrodimou, et al.
Thorax|September 14, 2013
Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosisGregory J Keir, Benjamin Garfield, David M Hansell, et al.
American Journal of Respiratory and Critical Care Medicine|April 19, 2016
Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary FibrosisAnne-Marie Russell, Huzaifa Adamali, Philip L Molyneaux, et al.
BMJ Open Respiratory Research|April 9, 2019
Sarcoidosis in the UK: insights from British Thoracic Society registry dataMuhunthan Thillai, William Chang, Nazia Chaudhuri, et al.
Pageof 40

Showing results (131-140 of 391) with videos related to

Sort By:
Pageof 40
Thorax|March 22, 2013
Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatmentHarpreet K Lota, Gregory J Keir, David M Hansell, et al.
The European Respiratory Journal|April 23, 2016
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosisMichael Kreuter, Marlies S Wijsenbeek, Martina Vasakova, et al.
ERJ Open Research|February 17, 2022
Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung diseaseKarim Boustani, Poonam Ghai, Rachele Invernizzi, et al.
Advances in Therapy|May 27, 2020
Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USAAmy L Olson, Toby M Maher, Valentina Acciai, et al.
International Journal of Molecular Sciences|November 14, 2019
The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary FibrosisPaolo Spagnolo, Philip L Molyneaux, Nicol Bernardinello, et al.
Lung|May 13, 2025
Kappa and Mu Opioid Receptors in Chronic Cough: Current Evidence and Future TreatmentSurinder S Birring, Peter V Dicpinigaitis, Toby M Maher, et al.
Frontiers in Immunology|July 5, 2021
Enhanced IL-1β Release Following NLRP3 and AIM2 Inflammasome Stimulation Is Linked to mtROS in Airway Macrophages in Pulmonary FibrosisAthina Trachalaki, Eliza Tsitoura, Semeli Mastrodimou, et al.
Thorax|September 14, 2013
Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosisGregory J Keir, Benjamin Garfield, David M Hansell, et al.
American Journal of Respiratory and Critical Care Medicine|April 19, 2016
Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary FibrosisAnne-Marie Russell, Huzaifa Adamali, Philip L Molyneaux, et al.
BMJ Open Respiratory Research|April 9, 2019
Sarcoidosis in the UK: insights from British Thoracic Society registry dataMuhunthan Thillai, William Chang, Nazia Chaudhuri, et al.
Pageof 40